By Seth Borenstein

Earth simmered to the sixth hottest year on record in 2021, according to several newly released temperature measurements.

And scientists say the exceptionally hot year is part of a long-term warming trend that shows hints of accelerating.

Two U.S. science agencies — NASA and the National Oceanic and Atmospheric Administration — and a private measuring group released their calculations for last year's global temperature on Thursday, and all said it wasn’t far behind ultra-hot 2016 and 2020.

Six different calculations found 2021 was between the fifth and seventh hottest year since the late 1800s. NASA said 2021 tied with 2018 for sixth warmest, while NOAA puts last year in sixth place by itself, ahead of 2018.

Scientists say a La Nina — natural cooling of parts of the central Pacific that changes weather patterns globally and brings chilly deep ocean water to the surface — dampened global temperatures just as its flip side, El Nino, boosted them in 2016.

Still, they said 2021 was the hottest La Nina year on record and that the year did not represent a cooling off of human-caused climate change but provided more of the same heat.

“So it’s not quite as headline-dominating as being the warmest on record, but give it another few years and we’ll see another one of those” records, said climate scientist Zeke Hausfather of the Berkeley Earth monitoring group that also ranked 2021 the sixth hottest. “It’s the long-term trend, and it’s an indomitable march upward.”

Gavin Schmidt, the climate scientist who heads NASA’s temperature team, said “the long-term trend is very, very clear. And it’s because of us. And it’s not going to go away until we stop increasing the amount of carbon dioxide in the atmosphere.”

The last eight years have been the eight hottest on record, NASA and NOAA data agree. Global temperatures, averaged over a 10-year period to take out natural variability, are nearly 2 degrees (1.1 degrees Celsius) warmer than 140 years ago, their data shows.

The other 2021 measurements came from the Japanese Meteorological Agency and satellite measurements by Copernicus Climate Change Service i n Europe and the University of Alabama in Huntsville.

There was such a distinctive jump in temperatures about eight to 10 years ago that scientists have started looking at whether the rise in temperatures is speeding up. Both Schmidt and Hausfather said early signs point to that but it's hard to know for sure.

“I think you can see the acceleration, but whether it’s statistically robust is not quite clear,” Schmidt said in an interview. “If you just look at the last the last 10 years, how many of them are way above the trend line from the previous 10 years? Almost all of them.”

The global average temperature last year was 58.5 degrees (14.7 Celsius), according to NOAA. In 1988, NASA’s then-chief climate scientist James Hansen grabbed headlines when he testified to Congress about global warming in a year that was the hottest on record at the time. Now, the 57.7 degrees (14.3 Celsius) of 1988 ranks as the 28th hottest year on record.

Last year, 1.8 billion people in 25 Asian, African and Middle Eastern nations had their hottest years on record, including China, Nigeria, Bangladesh, Iran, Myanmar and South Korea, according to Berkeley Earth.

The deep ocean, where most heat is stored in the seas, also set a record for warmth in 2021, according to a separate new study.

“Ocean warming, aside from causing coral bleaching and threatening sea life and fish populations we rely upon for roughly 25% of our protein intake globally, is destabilizing Antarctic ice shelves and threatens massive ... sea level rise if we don’t act,” said study co-author Michael Mann, a Pennsylvania State University climate scientist.

The last time Earth had a cooler than normal year by NOAA or NASA calculations was 1976. That means 69% of the people on the planet — more than 5 billion people under age 45 — have never experienced such a year, based on United Nations data.

North Carolina state climatologist Kathie Dello, 39, who wasn’t part of the new reports but said they make sense, said, “I’ve only lived in a warming world and I wish that the younger generations did not have to say the same. It didn’t have to be this way.”

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
Maker of First FDA-Approved Portable MRI Machine Hyperfine Goes Public
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Nomi Health Closes $110 Million to Further Scale Its Direct Healthcare Model Nationwide
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
Delta Airlines CEO Calls for Shortened Quarantine Times Amid Staffing Shortage
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
Load More